Fruit and vegetable consumption and its contribution to inequalities in life expectancy and disability-free life expectancy in ten European countries.


Journal

International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 13 01 2019
accepted: 14 05 2019
revised: 04 03 2019
pubmed: 12 6 2019
medline: 8 11 2019
entrez: 12 6 2019
Statut: ppublish

Résumé

To assess to what extent educational differences in total life expectancy (TLE) and disability-free life expectancy (DFLE) could be reduced by improving fruit and vegetable consumption in ten European countries. Data from national census or registries with mortality follow-up, EU-SILC, and ESS were used in two scenarios to calculate the impact: the upward levelling scenario (exposure in low educated equals exposure in high educated) and the elimination scenario (no exposure in both groups). Results are estimated for men and women between ages 35 and 79 years. Varying by country, upward levelling reduced inequalities in DFLE by 0.1-1.1 years (1-10%) in males, and by 0.0-1.3 years (0-18%) in females. Eliminating exposure reduced inequalities in DFLE between 0.6 and 1.7 years for males (6-15%), and between 0.1 years and 1.8 years for females (3-20%). Upward levelling of fruit and vegetable consumption would have a small, positive effect on both TLE and DFLE, and could potentially reduce inequalities in TLE and DFLE.

Identifiants

pubmed: 31183533
doi: 10.1007/s00038-019-01253-w
pii: 10.1007/s00038-019-01253-w
pmc: PMC6614160
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

861-872

Subventions

Organisme : Horizon 2020
ID : 633666

Références

Eur J Clin Nutr. 2000 Sep;54(9):706-14
pubmed: 11002383
Am J Clin Nutr. 2002 Jul;76(1):93-9
pubmed: 12081821
J Nutr. 2003 Jan;133(1):199-204
pubmed: 12514290
Am J Epidemiol. 2004 Dec 15;160(12):1223-33
pubmed: 15583375
Bull World Health Organ. 2005 Feb;83(2):100-8
pubmed: 15744402
Lancet. 2006 Jan 28;367(9507):320-6
pubmed: 16443039
J Am Diet Assoc. 2006 May;106(5):737-9
pubmed: 16647334
J Nutr. 2006 Oct;136(10):2588-93
pubmed: 16988131
Soz Praventivmed. 2006;51(3):153-61
pubmed: 17191540
Am J Clin Nutr. 2007 Jun;85(6):1634-42
pubmed: 17556703
Proc Nutr Soc. 2008 Aug;67(3):253-6
pubmed: 18452640
N Engl J Med. 2008 Jun 5;358(23):2468-81
pubmed: 18525043
Public Health Nutr. 2009 Nov;12(11):2174-82
pubmed: 19402946
J Clin Epidemiol. 2010 Aug;63(8):892-9
pubmed: 20171842
BMC Public Health. 2012 Mar 21;12:218
pubmed: 22436087
Eur J Nutr. 2012 Sep;51(6):637-63
pubmed: 22684631
J Epidemiol Community Health. 2013 Jan;67(1):56-62
pubmed: 22760220
Am J Epidemiol. 2013 Aug 15;178(4):590-602
pubmed: 23599238
Am J Clin Nutr. 2013 Aug;98(2):454-9
pubmed: 23803880
BMJ. 2013 Jul 23;347:f4240
pubmed: 23881930
Soc Sci Med. 2013 Oct;94:1-8
pubmed: 23931939
Eur J Epidemiol. 2013 Dec;28(12):959-71
pubmed: 24242935
Eur J Cancer. 2014 May;50(8):1498-509
pubmed: 24613128
J Epidemiol Community Health. 2014 Sep;68(9):856-62
pubmed: 24687909
Soc Sci Med. 2015 Feb;127:51-62
pubmed: 24932917
BMJ. 2014 Jul 29;349:g4490
pubmed: 25073782
Eur J Epidemiol. 2014 Sep;29(9):639-52
pubmed: 25154553
BMC Med Res Methodol. 2015 Jan 02;15:1
pubmed: 25555466
Lung Cancer. 2015 May;88(2):124-30
pubmed: 25747805
BMC Public Health. 2015 May 02;15:457
pubmed: 25934496
Eur J Public Health. 2015 Oct;25(5):849-56
pubmed: 26009611
J Epidemiol Community Health. 2016 Apr;70(4):331-8
pubmed: 26546286
PLoS Med. 2015 Dec 01;12(12):e1001909
pubmed: 26625134
Nutrition. 2016 Mar;32(3):296-302
pubmed: 26691768
Int J Clin Exp Med. 2015 Oct 15;8(10):18455-61
pubmed: 26770452
Sci Rep. 2016 Jan 25;6:19783
pubmed: 26806285
Int J Behav Nutr Phys Act. 2016 Jan 25;13:9
pubmed: 26810760
BMJ. 2016 Apr 11;353:i1732
pubmed: 27067249
J Aging Health. 2016 Oct;28(7):1315-38
pubmed: 27590804
Int J Public Health. 2017 Jan;62(1):127-141
pubmed: 27942745
Int J Epidemiol. 2017 Jun 1;46(3):1029-1056
pubmed: 28338764
Arch Public Health. 2018 May 28;76:25
pubmed: 29881544
HSMHA Health Rep. 1971 Apr;86(4):347-54
pubmed: 5554262

Auteurs

Adája E Baars (AE)

Department of Public Health, Erasmus MC, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. a.baars@erasmusmc.nl.

Jose R Rubio-Valverde (JR)

Department of Public Health, Erasmus MC, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.

Yannan Hu (Y)

Department of Public Health, Erasmus MC, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.

Matthias Bopp (M)

Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zurich, Switzerland.

Henrik Brønnum-Hansen (H)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Ramune Kalediene (R)

Department of Health Management, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Mall Leinsalu (M)

Stockholm Centre for Health and Social Change, Södertörn University, Stockholm, Sweden.
Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia.

Pekka Martikainen (P)

Population Research Unit, Faculty of Social Sciences, University of Helsinki, Helsinki, Finland.

Enrique Regidor (E)

Department of Public Health and Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, and CIBER Epidemiología y Salud Pública, Madrid, Spain.

Chris White (C)

Office for National Statistics, Public Policy Analysis Division, London, United Kingdom.

Bogdan Wojtyniak (B)

Department of Population Health Monitoring and Analysis, National Institute of Public Health, Warsaw, Poland.

Johan P Mackenbach (JP)

Department of Public Health, Erasmus MC, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.

Wilma J Nusselder (WJ)

Department of Public Health, Erasmus MC, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH